Global Implantable Infusion Pumps Market By Product (Piston Type Infusion Pumps, Creeping Type Infusion Pumps), Application (Cancer Treatment, Spasticity, Analgesia, Diabetes Mellitus, Others), End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others), Geography (Europe, North America, Asia Pacific, South America and Middle East & Africa.) – Industry Trends & Forecast to 2026
Market Analysis: Global Implantable Infusion Pumps Market
The global implantable infusion pumps market is expected to rise from its initial estimated value of USD 12579.90 million in 2018 to an estimated value of USD 19854.57 million by 2026 registering a CAGR of 5.87% in the forecast period of 2019-2026. This rise in the market can be attributed to the rising in animal adoption, increase in occurrence of injuries and diseases in animals, and the technological advancements.
Market Definition: Global Implantable Infusion Pumps Market
Implantable infusion pump is a medical device which is designed to deliver long-term drug infusion to the patients through intra-arterial, intra venous, subcutaneous, intraperitoneal, intrathecal route and epidural. They are usually used for specific drugs, dosages, and routes of administration and require a high level of sophistication in the technology to run these pumps as pump is surgically set in a subcutaneous pocket in the abdominal wall, and a catheter is strung into the desired place.
- Global rising of incidence rate of cancer, diabetes and obesity
- Increase in implantable drug delivery techniques in the surgeries acts as a market driver
- Product recalls and strict regulations for new products acting as a major market restraint
- Strict FDA policies for the approval of implantable infusion pumps
- Patient safety risks and medication errors in drug delivery related with implantable infusion pumps in the desired sites
Segmentation: Global Implantable Infusion Pumps Market
- By Product
- Piston Type Infusion Pumps
- Creeping Type Infusion Pumps
- By Application
- Cancer Treatment
- Cancer Pain
- Noncancerous Pain
- Mixed Sarcoma
- Skin Cancers
- Gastric Cancer
- Diabetes Mellitus
- Cancer Treatment
- By End-User
- Ambulatory Surgical Centers
- Specialty Clinics
- By Geography
- North America
- South America
- Rest of South America
- United Kingdom
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
- South Africa
- Saudi Arabia
- United Arab Emirates
- Rest of Middle East and Africa
- North America
Key Developments in the Market:
In February, 2018, Becton Dickinson (BD) acquired C. R. Bard in a deal worth USD 24billion.
In February, 2017,Insulet which is an innovative medical device company, has acquired U.S. Manufacturing facility in Acton, Massachusetts to start a U.S. manufacturing location in the United States.
In September, 2017, Fresenius Kabi acquired Merck KGaA’s biosimilars business
Competitive Analysis: Global Implantable Infusion Pumps Market
The global implantable infusion pumps market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of arthroscopy instruments market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.
Key Market Competitors: Global Implantable Infusion Pumps Market
Few of the major market competitors currently working in the implantable infusion pumps market are BD, Baxter, ICU Medical, Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Medtronic, Smiths Medical, TERUMO CORPORATION, Moog Inc., F. Hoffmann-La Roche Ltd, O&M Halyard or its affiliates., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Micrel Medical, Insulet Corporation.
Research Methodology: Global Implantable Infusion Pumps Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request An Analyst Call or can drop down your inquiry.
The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Reasons to Purchase this Report:
- Current and future of global implantable infusion pumps market outlook in the developed and emerging markets
- The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
- Regions/Countries that are expected to witness the fastest growth rates during the forecast period
- The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
- All segmentation provided above in this report is represented at country level
- All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)